Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Néoplasie

28. Octobre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3669


	Articles 1 - 20 / 73364

	Comparative efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic agents for unresectable hepatocellular carcinoma in patients with Child-Pugh A versus B cirrhosis: a single-center, retrospective study. BMC Cancer Liu D, Yang Z, Wang L, Ma L, Hou W, Ren S, Zheng S, Lu J. PMID: 41146031 [PubMed - indexed for MEDLINE]
	DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms. Nat Commun Goeppert B, Charbel A, Toth R, Zhang Y, Tabbakh D, Albrecht T, Schrimpf D, de Mestier L, Cros J, Vogel MN, Chang DH, Bohn EM, Brobeil A, Ji J, Singer S, Nazarov PV, Perren A, Apostolidis L, von Deimling A, Roessler S. PMID: 41145514 [PubMed - indexed for MEDLINE]
	Air Pollution and the Risk of Liver Cancer Incidence and Mortality: A Systematic Review and Meta-Analysis. Liver Int Yu G, Cui Y, Kang R, Wu J, Ge W, Han J. PMID: 41144931 [PubMed - indexed for MEDLINE]
	Comparison of Risk Factors, Their Interaction Patterns, and Scoring Systems for Liver Cancer Between Patients With and Those Without Diabetes: Retrospective Cohort Study Using Electronic Health Records and Tree-Structured Algorithms. JMIR Med Inform Yau STY, Hung CT, Leung EYM, Lee A, Yeoh EK. PMID: 41144600 [PubMed - indexed for MEDLINE]
	Role of the Wnt/Î²-catenin signaling pathway in the development of HCC. Front Immunol Lin B, Li M. PMID: 41142820 [PubMed - indexed for MEDLINE]
	On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information. Front Immunol Hattenhauer T, Mispelbaum R, Heine A, Schwab K, Brossart P, Klümper N, Saal J. PMID: 41142780 [PubMed - indexed for MEDLINE]
	Mendelian randomization and nomogram-based prediction of hepatocellular carcinoma risk in patients with hepatitis B cirrhosis. PeerJ Zheng X, Hong Y, Wei W. PMID: 41142312 [PubMed - indexed for MEDLINE]
	Impact of Liver and Primary Tumor Localization on Survival in Lung Metastasectomy for Colorectal Carcinoma. Ann Thorac Cardiovasc Surg Duman S, Erdo, Sar, Çuhatutar , Özkan B, Demir A, Kara M. PMID: 41139484 [PubMed - indexed for MEDLINE]
	Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinoma. Clin Exp Med Núñez K, Sandow T, Burton J, Hibino M, Gimenez J, Cohen A, Mehta N, Thevenot P. PMID: 41137977 [PubMed - indexed for MEDLINE]
	Identification and validation of feature genes in hepatocellular carcinoma based on bioinformatics and machine learning: An observational study. Medicine (Baltimore) Ma J, Yao J, Zhang M, Zhao C, Pang J, Wen L, Zhang R, Wen Y, Mu B. PMID: 41137296 [PubMed - indexed for MEDLINE]
	Gut microbiota, colorectal cancer, and metastatic liver cancer: A Mendelian randomization analysis. Medicine (Baltimore) Su W, Wang Z, Wang X, Ma X, Zhao R. PMID: 41137283 [PubMed - indexed for MEDLINE]
	Utilizing CT-derived extracellular volume fraction to distinguish hepatocellular adenoma from focal nodular hyperplasia. Medicine (Baltimore) Be, Turan Gökçe D, Turhan N, Ökten RS. PMID: 41137254 [PubMed - indexed for MEDLINE]
	Unveiling causal links between serum amino acid levels and risk of hepatobiliary neoplasms by Mendelian randomization study. Medicine (Baltimore) Zhai A, Ren L, Zhong Y, Zou R, Yang S, Jin Y, Hu H, Li F. PMID: 41137215 [PubMed - indexed for MEDLINE]
	Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning. BMC Cancer Lee PC, Li PY, Lee CY, Lin SR, Wu CJ, Hung YW, Chen YH, Chan JW, Mon HC, Lee CJ, Chi CT, Lee IC, Hou MC, Chao Y, Huang YH, Lee JM. PMID: 41136986 [PubMed - indexed for MEDLINE]
	Serum tyrosine level is an independent factor for hepatocellular carcinoma development and mortality in patients with chronic liver disease. Sci Rep Oi M, Miwa T, Utakata Y, Aiba M, Unome S, Hanai T, Shiraki M, Katsumura N, Kawashima Y, Shimizu M. PMID: 41136546 [PubMed - indexed for MEDLINE]
	Comparison of the Effectiveness of Transarterial Bland Embolization and Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Propensity Score Matched Study of 980 Patients. J Vasc Interv Radiol Zhang H, Xu J, Meng H, Shen L. PMID: 41135980 [PubMed - indexed for MEDLINE]
	MRI-based Intra- and Peritumoral Heterogeneity in Hepatocellular Carcinoma for Microvascular Invasion Prediction and Prognostic Risk Stratification. Radiol Imaging Cancer Zhang Y, Wang S, Song M, Sheng R, Geng Z, Zhang W, Zeng M. PMID: 41134139 [PubMed - indexed for MEDLINE]
	Reproducibility Examination of Histopathological Growth Patterns of Liver Metastases in a Retrospective, Consecutive, Single-Center, Cohort Study with Literature Review. Med Sci (Basel) Sejben A, Almási S, Pósfai B, Baráth B, Ferenczi Á, Abbasi P, Zombori T, Lantos T. PMID: 41133502 [PubMed - indexed for MEDLINE]
	Mitochondrial gatekeeper in hepatocellular carcinoma: Unraveling the multifaceted roles of VDAC in metabolic reprogramming, apoptosis evasion and therapeutic innovation (Review). Mol Med Rep Wang J, Liang Y, Jia X, Yang X, Shi D, Wang Y, Pan Y. PMID: 41133474 [PubMed - indexed for MEDLINE]
	Programmed cell death-related genes define distinct molecular subtypes and risk profiles in hepatocellular carcinoma. Sci Rep Yang H, Liu Q, Cao S, Fang H, Li J, Shi X, Pang C, Lu D, Zhao X, Li J, Wang S, Wu T. PMID: 41131074 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 73364

Page 1 de 3669



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité